Patents, Innovation and Access To New Pharmaceuticals

The report considers the role of intellectual property rights in the development of an access to new pharmaceuticals. A number of studies have found patents are significantly more important to pharmaceutical firms in appropriating the benefits from innovation compared to other high-tech industries. The final section of the paper focuses on the need for an orphan drug type program to stimulate more research and development on diseases specific to third world countries.